although the risk of anaesthesia in patients undergoing cardiac transplantation is high , anaesthesia-related morbidity and mortality is extremely low , if management is based on adequate organ-preserving therapy , adaptation of anaesthetic techniques to the deranged myocardial function that characterizes end-stage cardiac disease , prevention of aspiration , reduction of the immunosuppression-induced risk of infection and consideration of the consequences of heart denervation .
C0018823
cardiac transplantation
C0178784
organ